Effect of Nicotine on Chronic Pelvic Pain
CompletedPhase 4NCT00440505
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The purpose of this study is to test whether transdermal nicotine reduces pain among women with chronic pelvic pain.
Study details
- Official title
- Effect of Nicotine on Chronic Pelvic Pain
- Conditions
- Interventions
- Drug: Placebo
- Drug: Nicotine (5 mg)
- Drug: Nicotine (10 mg)
- Sponsor
- Columbia University
- Start date
- 2004-02
- Primary completion
- 2008-06
- Sex
- Female
- Age range
- from 18 Years to 60 Years
- Results posted
- Yes, on ClinicalTrials.gov
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Chronic pelvic pain * Aged 18-60 years * Female Exclusion Criteria: * Uncontrolled hypertension * Cardiovascular disease * Current analgesic abuse * Pregnancy * Current usage of nicotine patch or gum * Allergy to adhesive tape
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT00440505